MARC GENICOT: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
MARC GENICOT
Largest movements
- Cash -€34,859
down €34,859 (-62.7%), from €55,615 to €20,756
mainly Current investments (-€33,211) and Contributions, distributions and other (-€1,700)
- Current investments +€33,211
up €33,211 (+32.0%), from €103,770 to €136,981
No liability line moved by more than 1% of the balance sheet total.
- Financial charges +€4,875
up €4,875, from -€2,710 to €2,165
- Taxes -€1,553
down €1,553 (-61.2%), from €2,537 to €984
- Write-downs +€1,000
up €1,000 (+14.3%), from -€7,000 to -€6,000
- Financial income -€973
down €973 (-28.1%), from €3,460 to €2,487
- Gross operating margin -€697
down €697 (-29.9%), from -€2,334 to -€3,032
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €159,956 | €159,568 | -€388 | -0.2% |
| Current assets | 29/58 | €159,956 | €159,568 | -€388 | -0.2% |
| Amounts receivable within one year | 40/41 | €571 | €1,832 | +€1,261 | +221% |
| Other amounts receivable | 41 | €571 | €1,832 | +€1,261 | +221% |
| Current investments | 50/53 | €103,770 | €136,981 | +€33,211 | +32.0% |
| Cash at bank and in hand | 54/58 | €55,615 | €20,756 | -€34,859 | -62.7% |
| Total equity and liabilities | 10/49 | €159,956 | €159,568 | -€388 | -0.2% |
| Equity | 10/15 | €155,102 | €155,309 | +€207 | +0.1% |
| Contributions | 10/11 | €18,600 | €18,600 | = | 0.0% |
| Reserves | 13 | €134,119 | €134,119 | = | 0.0% |
| Non-distributable reserves | 130/1 | €6,990 | €6,990 | = | 0.0% |
| Reserves not available under the articles | 1311 | €6,990 | €6,990 | = | 0.0% |
| Distributable reserves | 133 | €127,129 | €127,129 | = | 0.0% |
| Profit (loss) carried forward | 14 | €2,382 | €2,589 | +€207 | +8.7% |
| Amounts payable | 17/49 | €4,854 | €4,259 | -€595 | -12.3% |
| Amounts payable within one year | 42/48 | €4,467 | €3,860 | -€607 | -13.6% |
| Trade debts | 44 | €348 | €0 | -€348 | -100% |
| Suppliers | 440/4 | €348 | €0 | -€348 | -100% |
| Other amounts payable | 47/48 | €4,118 | €3,860 | -€259 | -6.3% |
| Accrued charges and deferred income | 492/3 | €387 | €400 | +€12 | +3.2% |
| Write-downs on stocks, contracts in progress and trade receivables: additions (reversals) | 631/4 | -€7,000 | -€6,000 | +€1,000 | +14.3% |
| Other operating charges | 640/8 | €387 | €400 | +€12 | +3.2% |
| Gross operating margin | 9900 | -€2,334 | -€3,032 | -€697 | -29.9% |
| Operating profit (loss) | 9901 | €4,278 | €2,569 | -€1,710 | -40.0% |
| Financial income | 75/76B | €3,460 | €2,487 | -€973 | -28.1% |
| Recurring financial income | 75 | €3,460 | €2,487 | -€973 | -28.1% |
| Financial charges | 65/66B | -€2,710 | €2,165 | +€4,875 | |
| Recurring financial charges | 65 | -€2,710 | €2,165 | +€4,875 | |
| Profit (loss) for the period before taxes | 9903 | €10,448 | €2,890 | -€7,557 | -72.3% |
| Income taxes | 67/77 | €2,537 | €984 | -€1,553 | -61.2% |
| Profit (loss) for the period | 9904 | €7,911 | €1,907 | -€6,004 | -75.9% |
| Profit (loss) for the period to be appropriated | 9905 | €7,911 | €1,907 | -€6,004 | -75.9% |
Source: filed annual accounts (NBB), financial years ended 30 June 2024 and 30 June 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 20 October 2026 via checked.be.